8:15 AM ET
8-K
Business Update
Orchestra BioMed Holdings Business Update
Orchestra BioMed exceeded its enrollment target for the BACKBEAT Global Pivotal Trial, randomizing 330 patients across 81 sites globally. The trial is evaluating AVIM Therapy for uncontrolled hypertension in pacemaker patients in collaboration with Medtronic. The company expects to submit primary endpoint data for presentation at a major cardiovascular conference in Q2 2027.
- Counterparty
- Medtronic plc